Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
797
mi
from 43215
Metairie, LA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
797
mi
from 43215
Metairie, LA
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
762
mi
from 43215
Norfolk, NE
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
762
mi
from 43215
Norfolk, NE
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
682
mi
from 43215
Omaha, NE
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
414
mi
from 43215
Syracuse, NY
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
414
mi
from 43215
Syracuse, NY
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
64
mi
from 43215
Dayton, OH
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
64
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
6
mi
from 43215
Grove City, OH
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
6
mi
from 43215
Grove City, OH
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
2015
mi
from 43215
Gresham, OR
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
2015
mi
from 43215
Gresham, OR
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
212
mi
from 43215
Erie, PA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
212
mi
from 43215
Erie, PA
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
362
mi
from 43215
Tullahoma, TN
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
362
mi
from 43215
Tullahoma, TN
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
937
mi
from 43215
Fort Worth, TX
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
937
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
991
mi
from 43215
Houston, TX
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
1515
mi
from 43215
Layton, UT
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
1515
mi
from 43215
Layton, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
1508
mi
from 43215
Orem, UT
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
1508
mi
from 43215
Orem, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
1747
mi
from 43215
Provo, UT
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
1747
mi
from 43215
Provo, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
1517
mi
from 43215
Roy, UT
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
1517
mi
from 43215
Roy, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
1518
mi
from 43215
South Jordan, UT
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
1518
mi
from 43215
South Jordan, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
1517
mi
from 43215
West Jordan, UT
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
1517
mi
from 43215
West Jordan, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
317
mi
from 43215
Burke, VA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
317
mi
from 43215
Burke, VA
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
2039
mi
from 43215
Sacramento, CA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
2039
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
1160
mi
from 43215
Thornton, CO
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
1160
mi
from 43215
Thornton, CO
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
993
mi
from 43215
Miami Beach, FL
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
993
mi
from 43215
Miami Beach, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
198
mi
from 43215
Bardstown, KY
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
198
mi
from 43215
Bardstown, KY
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
721
mi
from 43215
Lincoln, NE
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
721
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
1962
mi
from 43215
Anaheim, CA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
1962
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
Evaluation of the School Kids Influenza Prevention Project
Evaluation of a Text Based Reminder Recall System to Increase Utilization of the School Kids Influenza Prevention Project and Increase Influenza Vaccination Rates in Monroe County, NY
Status: Enrolling
Updated:  3/9/2018
Univ of Rochester Medical Center
354
mi
from 43215
Rochester, NY
Evaluation of the School Kids Influenza Prevention Project
Evaluation of a Text Based Reminder Recall System to Increase Utilization of the School Kids Influenza Prevention Project and Increase Influenza Vaccination Rates in Monroe County, NY
Status: Enrolling
Updated: 3/9/2018
Univ of Rochester Medical Center
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.
Phase IV, Pilot, Randomized, Investigator-blinded, Study to Evaluate the Reactogenicity and Immunogenicity of Standard-dose Versus High-dose Inactivated Influenza Vaccine After Kidney, Heart and Lung Transplantation.
Status: Enrolling
Updated:  3/12/2018
Inova Fairfax Hospital
318
mi
from 43215
Falls Church, VA
Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.
Phase IV, Pilot, Randomized, Investigator-blinded, Study to Evaluate the Reactogenicity and Immunogenicity of Standard-dose Versus High-dose Inactivated Influenza Vaccine After Kidney, Heart and Lung Transplantation.
Status: Enrolling
Updated: 3/12/2018
Inova Fairfax Hospital
318
mi
from 43215
Falls Church, VA
Click here to add this to my saved trials
Immune Response Following Seasonal Influenza Vaccination
Extent and Durability of Immune Response Following Seasonal Influenza Vaccination in Healthy Volunteers
Status: Enrolling
Updated:  3/16/2018
Optimal Health Research
316
mi
from 43215
Rockville, MD
Immune Response Following Seasonal Influenza Vaccination
Extent and Durability of Immune Response Following Seasonal Influenza Vaccination in Healthy Volunteers
Status: Enrolling
Updated: 3/16/2018
Optimal Health Research
316
mi
from 43215
Rockville, MD
Click here to add this to my saved trials
QuickVue Influenza A + B Test Field Study
QuickVue Influenza A + B Test Field Study
Status: Enrolling
Updated:  3/16/2018
Alliance Urgent Care
1672
mi
from 43215
Phoenix, AZ
QuickVue Influenza A + B Test Field Study
QuickVue Influenza A + B Test Field Study
Status: Enrolling
Updated: 3/16/2018
Alliance Urgent Care
1672
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
QuickVue Influenza A + B Test Field Study
QuickVue Influenza A + B Test Field Study
Status: Enrolling
Updated:  3/16/2018
Twelve Corners Pediatrics
356
mi
from 43215
Rochester, NY
QuickVue Influenza A + B Test Field Study
QuickVue Influenza A + B Test Field Study
Status: Enrolling
Updated: 3/16/2018
Twelve Corners Pediatrics
356
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
QuickVue Influenza A + B Test Field Study
QuickVue Influenza A + B Test Field Study
Status: Enrolling
Updated:  3/16/2018
Veritas, PA
1016
mi
from 43215
Belton, TX
QuickVue Influenza A + B Test Field Study
QuickVue Influenza A + B Test Field Study
Status: Enrolling
Updated: 3/16/2018
Veritas, PA
1016
mi
from 43215
Belton, TX
Click here to add this to my saved trials
QuickVue Influenza A + B Test Field Study
QuickVue Influenza A + B Test Field Study
Status: Enrolling
Updated:  3/16/2018
City Doc Urgent Care
909
mi
from 43215
Dallas, TX
QuickVue Influenza A + B Test Field Study
QuickVue Influenza A + B Test Field Study
Status: Enrolling
Updated: 3/16/2018
City Doc Urgent Care
909
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
QuickVue Influenza A + B Test Field Study
QuickVue Influenza A + B Test Field Study
Status: Enrolling
Updated:  3/16/2018
Advanced Pediatrics
316
mi
from 43215
Vienna, VA
QuickVue Influenza A + B Test Field Study
QuickVue Influenza A + B Test Field Study
Status: Enrolling
Updated: 3/16/2018
Advanced Pediatrics
316
mi
from 43215
Vienna, VA
Click here to add this to my saved trials
Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy
Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy
Status: Enrolling
Updated:  3/17/2018
Midwestern University/Northwestern Memorial Hospital
289
mi
from 43215
Chicago, IL
Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy
Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy
Status: Enrolling
Updated: 3/17/2018
Midwestern University/Northwestern Memorial Hospital
289
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
1644
mi
from 43215
Mesa, AZ
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
1644
mi
from 43215
Mesa, AZ
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
828
mi
from 43215
Clearwater, FL
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
828
mi
from 43215
Clearwater, FL
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
761
mi
from 43215
DeLand, FL
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
761
mi
from 43215
DeLand, FL
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
948
mi
from 43215
Delray Beach, FL
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
948
mi
from 43215
Delray Beach, FL
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
672
mi
from 43215
Jacksonville, FL
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
672
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
274
mi
from 43215
Chicago, IL
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
780
mi
from 43215
Wichita, KA
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
780
mi
from 43215
Wichita, KA
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
156
mi
from 43215
Lexington, KY
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
156
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
331
mi
from 43215
Columbia, MD
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
331
mi
from 43215
Columbia, MD
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
318
mi
from 43215
Rockville, MD
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
318
mi
from 43215
Rockville, MD
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
617
mi
from 43215
Milford, MA
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
617
mi
from 43215
Milford, MA
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
616
mi
from 43215
Kansas City, MO
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
616
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
450
mi
from 43215
Somers Point, NJ
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
450
mi
from 43215
Somers Point, NJ
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
398
mi
from 43215
Binghamton, NY
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
398
mi
from 43215
Binghamton, NY
Click here to add this to my saved trials
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated:  3/19/2018
GSK Investigational Site
407
mi
from 43215
Camillus, NY
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
A Study to Evaluate the Safety, Immunogenicity, and Relative Efficacy of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Adults Aged 18 Years and Older
Status: Enrolling
Updated: 3/19/2018
GSK Investigational Site
407
mi
from 43215
Camillus, NY
Click here to add this to my saved trials